PHARMACYTE BIOTECH INC (PMCB) Stock News

USA - Nasdaq - NASDAQ:PMCB - US71715X2036 - Common Stock

1.22 USD

+0.01 (+0.83%)

Last: 12/5/2025, 8:00:00 PM

1.15 USD

-0.07 (-5.74%)

After Hours: 12/5/2025, 8:00:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

PMCB Latest News, Press Relases and Analysis

All

Press Releases

a day ago - By: Chartmill - Mentions: IRBT TLYS CAPR KITT ...

News Image

On Friday, there are stocks with unusual volume. Let's take a look.

2 days ago - By: Chartmill - Mentions: PTN GCO CCRN SUPX ...

News Image

Keep an eye on the top gainers and losers in Thursday's session.

2 days ago - By: Chartmill - Mentions: PLUG NVDA PATH ONDS ...

News Image

Which stocks are most active on Thursday?

2 days ago - By: Chartmill - Mentions: MVO GCO CCRN RGC ...

News Image

Let's take a look at the stocks that are in motion in today's session.

2 days ago - By: Chartmill - Mentions: IRBT GCO CCRN BBW ...

News Image

Gapping stocks in Thursday's session

11 days ago - By: Chartmill - Mentions: URBN WOOF HPQ INV ...

News Image

Get insights into the top gainers and losers of Tuesday's after-hours session.

11 days ago - By: Stocktwits - Mentions: FEMY QCLS

PMCB Stock Jumps 25% After Company Sells Stake In Femasys

11 days ago - By: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

3 months ago - By: PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

4 months ago - By: PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing

4 months ago - By: Benzinga - Mentions: IBIO SNGX SNTI VKTX ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

4 months ago - By: PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors

2 years ago - By: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease

2 years ago - By: BusinessInsider

News Image

PMCB Stock Earnings: PharmaCyte Biotech Reported Results for Q3 2024

2 years ago - By: InvestorPlace

PMCB Stock Earnings: PharmaCyte Biotech Reported Results for Q3 2024

2 years ago - By: InvestorPlace

PMCB Stock Earnings: PharmaCyte Biotech Reported Results for Q2 2024

2 years ago - By: BusinessInsider

News Image

PMCB Stock Earnings: PharmaCyte Biotech Reported Results for Q2 2024

2 years ago - By: PharmaCyte Biotech, Inc. - Mentions: FEMY

PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.

2 years ago - By: Femasys Inc. - Mentions: FEMY

Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech

2 years ago - By: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology

2 years ago - By: Seeking Alpha

PharmaCyte stock completes tender offer to purchase shares

2 years ago - By: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Announces Final Results of Tender Offer

3 years ago - By: Benzinga - Mentions: AMPE SBFM PHAR CDNA ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session

3 years ago - By: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000 Shares at $3.25 Per Share

3 years ago - By: PharmaCyte Biotech, Inc.

PharmaCyte Biotech to Implement Second $10-Million Share Repurchase Plan

3 years ago - By: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value

3 years ago - By: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Reaches Cooperation Agreement with Iroquois Capital

3 years ago - By: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Rebukes Iroquois’ Commencement of Consent Solicitation

3 years ago - By: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Commences First Phase of Two-Phase Pig Study

3 years ago - By: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Reports Positive Interim Results in Malignant Ascites Mouse Model Study

3 years ago - By: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Announces Preliminary Unaudited Financial Results for Fiscal Year 2022

3 years ago - By: Iroquois Capital Management, LLC

News Image

IROQUOIS CAPITAL COMMENCES CONSENT SOLICITATION TO RECONSTITUTE PHARMACYTE BIOTECH BOARD OF DIRECTORS

3 years ago - By: Iroquois Capital Management, LLC

News Image

IROQUOIS CAPITAL ISSUES STATEMENT IN RESPONSE TO RECENT ACTIONS BY THE PHARMACYTE BIOTECH BOARD OF DIRECTORS